盐酸莫洛替尼，CAS 登记号 1841094-17-4，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 盐酸莫洛替尼 的 CAS 号：1841094-17-4，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Momelotinib Hydrochlode · CAS 1841094-17-4 · C23H26Cl2N6O3. UNII LDX8893L5D.
| CAS Registry Number | 1841094-17-4 |
|---|---|
| PubChem CID | 102514733 |
| Molecular formula | C23H26Cl2N6O3 |
| IUPAC name | N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide;hydrate;dihydrochloride |
| UNII (FDA) | LDX8893L5D |
| Molecular Weight | 505.4 |
|---|---|
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | 504.1443441 |
| Monoisotopic Mass | 504.1443441 |
| Topological Polar Surface Area | 104 |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 615 |
| Reported hazard statements | H302 (100%), H373 (100%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H373 (100%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]
Momelotinib dihydrochloride monohydrate; CYT-387 dihydrochloride monohydrate; LDX8893L5D; CYT-11387 dihydrochloride monohydrate; MOMELOTINIB HYDROCHLORIDE HYDRATE; Momelotinib hydrochloride hydrate (JAN); MOMELOTINIB HYDROCHLORIDE HYDRATE [JAN]; N-(Cyanomethyl)-4-(2-(4-(morpholin-4-yl)anilino)pyrimidin-4-yl)benzamide dihydrochloride monohydrate; N-(Cyanomethyl)-4-{2-[4-(morpholin-4-yl)anilino]pyrimidin-4-yl}benzamide dihydrochloride monohydrate; RefChem:159402; UNII-LDX8893L5D; Ojjaara; 1841094-17-4; Ojjaara (TN); Omjjara (TN); CHEMBL6068336
CAS 1841094-17-4; molecular formula C23H26Cl2N6O3; molecular weight — g/mol.
Momelotinib dihydrochloride monohydrate, CYT-387 dihydrochloride monohydrate, LDX8893L5D, CYT-11387 dihydrochloride monohydrate, MOMELOTINIB HYDROCHLORIDE HYDRATE, Momelotinib hydrochloride hydrate (JAN).
Hazard statements reported: H302, H373.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.